[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Berkeley faculty statement on scholarly publishing
- To: <liblicense-l@lists.yale.edu>
- Subject: RE: Berkeley faculty statement on scholarly publishing
- From: "Matthew Cockerill" <matt@biomedcentral.com>
- Date: Fri, 13 May 2005 23:47:36 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
> "Seen in that context, the cost of scientific publishing, even with the > existing inefficiencies, is relatively affordable, in that it amounts > only to a few percent of the overall cost of what the funders spend > doing the scientific research in the first place." Peter Banks wrote: > To the naive--that is, most journalists and members of Congress--such > statements seem highly plausable. A few percent? Chump change in the > research enterprise! > > Except it isn't chump change, it's a diversion of research funding and a > net loss for science. It is a myth that Open Access is, somehow, a costly additional option that would have to be paid for on top of the existing publication process, resulting in a net additional cost for science. What are the additional costs in making research openly available, compared to making it available online under toll-access restrictions? They are negligible. As Harold Varmus and Mark Walport, amongst others, have repeatedly stated, there is no reason to suppose that Open Access publishing will involve any more costs than traditional publishing. The activities and costs involved in managing peer review etc are one and the same, whether those costs are paid upfront by the funders of the research, or after-the-fact, in the form of toll-based access. So from a macro-economic point of view, no additional funds should need to be diverted from science in order to deliver open access to scientific research publications. If the amount of science that gets published grows, then the total costs will go up, but that would be true whatever the model of payment/access. > Conducting less research to support open access might make sense were > there strong evidence to support the contention that OA will > "dramatically increase the effectiveness of scientific communication, > and therefore will help the progress of science." So far, however, that > proposition rests on faith, not evidence. Effective communication does > not consist in shoveling out reams and reams of manuscripts; it consists > in devilvering information in a way and at a time that empowers crtical > decision making, whether in patient care or research. Just as we now > insist upon evidence-based medicine, we need to insist on evidence based > informatics. A major public policy initative like OA needs more evidence > behind it that has so far been presented. While to some, the benefits of open access vs restricted access seem self-evident, I do agree that it is important that these benefits should not simply be taken for granted, but should be analysed and quantified. Evidence for the benefits of Open Access *is* now accruing rapidly. e.g. PNAS just reported that their open access articles, no average, receive 50% more accesses than their subscription-only articles in the first month after publication. This strongly suggests that, even for a widely read journal such as PNAS, there is plenty of demand for access to scientific research articles that is failing to be satisfied by the current subscription model. For less well-known journals, which are less widely subscribed to, one might expect the increase in rate of access to be even more pronounced - this can and should be tested. Also, recent developments in bibliometrics are showing that Open Access leads to research having more impact in terms of citations. e.g. http://eprints.rclis.org/archive/00002309/ Most of the citation impact studies done so far have relied on data from ISI, which tracks only a fraction of open access journals. The arrival of Google Scholar means that that the citation rates of *all* open access journals can now be tracked easily, and compared to traditional journals. This should result in some even more informative analyses in future. Regards, Matthew Cockerill, Ph.D. Director of Operations BioMed Central
- Prev by Date: Re: Berkeley faculty statement on scholarly publishing
- Next by Date: Visit to NASIG
- Previous by thread: Re: Berkeley faculty statement on scholarly publishing
- Next by thread: Re: Berkeley faculty statement on scholarly publishing
- Index(es):